Identification of histidine kinase inhibitors through screening of natural compounds to combat mastitis caused by Streptococcus agalactiae in dairy cattle DOI Creative Commons
Rajesh Kumar Pathak, Jun‐Mo Kim

Journal of Biological Engineering, Journal Year: 2023, Volume and Issue: 17(1)

Published: Sept. 26, 2023

Mastitis poses a major threat to dairy farms globally; it results in reduced milk production, increased treatment costs, untimely compromised genetic potential, animal deaths, and economic losses. Streptococcus agalactiae is highly virulent bacteria that cause mastitis. The administration of antibiotics for the this infection not advised due concerns about emergence antibiotic resistance potential adverse effects on human health. Thus, there critical need identify new therapeutic approaches combat One promising target development antibacterial therapies transmembrane histidine kinase bacteria, which plays key role signal transduction pathways, secretion systems, virulence, resistance.In study, we aimed novel natural compounds can inhibit kinase. To achieve goal, conducted virtual screening 224,205 compounds, selecting top ten based their lowest binding energy favorable protein-ligand interactions. Furthermore, molecular docking eight selected five inhibitors with was performed evaluate respect top-screened compounds. We also analyzed ADMET properties these assess drug-likeness. two (ZINC000085569031 ZINC000257435291) (Tetracycline) demonstrated strong affinity were subjected dynamics simulations (100 ns), free landscape, calculations using MM-PBSA method.Our suggest have serve as effective be utilized veterinary medicine mastitis after further validation through clinical studies.

Language: Английский

Physicochemical Property Determinants of Oral Absorption for PROTAC Protein Degraders DOI Creative Commons
Keith R. Hornberger, Erika Araujo

Journal of Medicinal Chemistry, Journal Year: 2023, Volume and Issue: 66(12), P. 8281 - 8287

Published: June 6, 2023

Heterobifunctional PROTAC degraders are gaining attention as a differentiated therapeutic modality with the potential for oral dosing in clinic. Belonging to beyond Rule of Five domain physicochemical property space, we have sought understand determinants absorption this class molecules rapid development novel agents. We collected large data set from that been dosed orally and intravenously rats estimate fraction absorbed dosing. Through estimation, effects differential hepatic clearance normalized, allowing better assessment absorption. demonstrate less permissive than mice. The properties then evaluated once compounds rank-ordered by absorbed. derive suggested design constraints on associated higher probability being

Language: Английский

Citations

75

Rule of five violations among the FDA-approved small molecule protein kinase inhibitors DOI Creative Commons
Robert Roskoski

Pharmacological Research, Journal Year: 2023, Volume and Issue: 191, P. 106774 - 106774

Published: April 17, 2023

Because genetic alterations including mutations, overexpression, translocations, and dysregulation of protein kinases are involved in the pathogenesis many illnesses, this enzyme family is target drug discovery programs pharmaceutical industry. Overall, US FDA has approved 74 small molecule kinase inhibitors, nearly all which orally effective. Of drugs, thirty-nine block receptor protein-tyrosine kinases, nineteen nonreceptor twelve directed against protein-serine/threonine four dual specificity kinases. The data indicate that 65 these medicinals for management neoplasms (51 solid tumors such as breast, colon, lung cancers, eight nonsolid leukemia, six both types tumors). Nine FDA-approved inhibitors form covalent bonds with their enzymes they accordingly classified TCIs (targeted inhibitors). Medicinal chemists have examined physicochemical properties drugs Lipinski's rule five (Ro5) a computational procedure used to estimate solubility, membrane permeability, pharmacological effectiveness drug-discovery setting. It relies on parameters molecular weight, number hydrogen bond donors acceptors, Log partition coefficient. Other important descriptors include lipophilic efficiency, polar surface area, rotatable aromatic rings. We tabulated other inhibitors. 30 fail comply five.

Language: Английский

Citations

50

Structural and Physicochemical Features of Oral PROTACs DOI
Markus Schade, James S. Scott, Thomas G. Hayhow

et al.

Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(15), P. 13106 - 13116

Published: July 30, 2024

Achieving oral bioavailability with Proteolysis Targeting Chimeras (PROTACs) is a key challenge. Here, we report the in vivo pharmacokinetic properties mouse, rat, and dog of four clinical PROTACs compare an internally derived data set. We use NMR to determine 3D molecular conformations structural preorganization free solution, introduce new experimental descriptors, solvent-exposed H-bond donors (eHBD), acceptors (eHBA). derive upper limit eHBD ≤ 2 for apolar environments show greater tolerance other (eHBA, polarity, lipophilicity, weight) than Rule-of-5 compliant drugs. Within set structurally related PROTACs, that examples > have much lower those 2. summarize our findings as "Rule-of-oral-PROTACs" order assist medicinal chemists achieve this challenging space.

Language: Английский

Citations

19

Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling DOI Creative Commons
Matthew I. J. Raybould, Oliver M. Turnbull,

Annabel Suter

et al.

Communications Biology, Journal Year: 2024, Volume and Issue: 7(1)

Published: Jan. 8, 2024

Abstract Antibodies with lambda light chains ( λ -antibodies) are generally considered to be less developable than those kappa κ -antibodies). Though this hypothesis has not been formally established, it led substantial systematic biases in drug discovery pipelines and thus contributed dominance amongst clinical-stage therapeutics. However, the identification of increasing numbers epitopes preferentially engaged by -antibodies shows there is a functional cost neglecting consider them as potential lead candidates. Here, we update our Therapeutic Antibody Profiler (TAP) tool use latest data machine learning-based structure prediction, apply evaluate developability risk profiles for based on their surface physicochemical properties. We find that while human average have higher issues -antibodies, sizeable proportion assigned lower-risk TAP should represent more tractable candidates therapeutic development. Through comparative analysis low- high-risk populations, highlight opportunities strategic design suggests would enrich -antibodies. Overall, provide context differing - enabling rational approach incorporate diversity into initial pool immunotherapeutic

Language: Английский

Citations

17

Hydrophobic deep eutectic solvent (HDES) as oil phase in lipid-based drug formulations DOI Creative Commons
Shaida Panbachi, Josef Beránek, Martin Kuentz

et al.

International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 661, P. 124418 - 124418

Published: July 2, 2024

There is increasing pharmaceutical interest in deep eutectic solvents not only as a green alternative to organic drug manufacturing, but also liquid formulation for delivery. The present work introduces hydrophobic solvent (HDES) the field of lipid-based formulations (LBF). Phase behavior mixture with 2:1 M ratio decanoic- dodecanoic acid was studied experimentally and described by thermodynamic modelling. Venetoclax selected model atomistic molecular dynamics simulations mixtures. As result, valuable insights were gained into interaction networks between different components. Moreover, HDES showed greatly enhanced solubilization compared conventional glyceride-based vehicles, aqueous dispersion limited. Hence surfactants their ability improve addition Tween 80 resulted lowest droplet sizes high vitro release. In conclusion, combination surfactant(s) provides novel LBF potential. However, components must be finely balanced keep integrity solubilizing HDES, while enabling sufficient

Language: Английский

Citations

11

Return to Flatland DOI
Ian Churcher,

Stuart Newbold,

Christopher W. Murray

et al.

Nature Reviews Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 31, 2025

Language: Английский

Citations

1

Extracting medicinal chemistry intuition via preference machine learning DOI Creative Commons
Oh-Hyeon Choung,

Riccardo Vianello,

Marwin Segler

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Oct. 31, 2023

The lead optimization process in drug discovery campaigns is an arduous endeavour where the input of many medicinal chemists weighed order to reach a desired molecular property profile. Building expertise successfully drive such projects collaboratively very time-consuming that typically spans years within chemist's career. In this work we aim replicate by applying artificial intelligence learning-to-rank techniques on feedback was obtained from 35 at Novartis over course several months. We exemplify usefulness learned proxies routine tasks as compound prioritization, motif rationalization, and biased de novo design. Annotated response data provided, developed models code made available through permissive open-source license.

Language: Английский

Citations

22

Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments DOI Creative Commons
Aurino M. Kemas, Reza Zandi Shafagh, Nayere Taebnia

et al.

Advanced Healthcare Materials, Journal Year: 2023, Volume and Issue: 13(11)

Published: Dec. 6, 2023

Organotypic and microphysiological systems (MPS) that can emulate the molecular phenotype function of human tissues, such as liver, are increasingly used in preclinical drug development. However, despite their improved predictivity, development success rates have remained low with most compounds failing clinical phases promising data. Here, it is tested whether absorption small molecules to polymers commonly for MPS fabrication impact pharmacological toxicological assessments contribute high failure rates. To this end, identical devices fabricated from eight different prototypic physicochemical properties analyzed. It found overall primarily driven by compound hydrophobicity number rotatable bonds. differ >1000-fold between polydimethyl siloxane (PDMS) being absorptive, whereas polytetrafluoroethylene (PTFE) thiol-ene epoxy (TEE) absorbed least. Strikingly, organotypic primary liver cultures successfully flagged hydrophobic hepatotoxins lowly absorbing TEE at therapeutically relevant concentrations, isogenic PDMS resistant, resulting false negative safety signals. Combined, these results guide selection materials facilitate assays translatability.

Language: Английский

Citations

20

Impact of Applicability Domains to Generative Artificial Intelligence DOI Creative Commons
Maxime Langevin, Christoph Grebner, Stefan Güssregen

et al.

ACS Omega, Journal Year: 2023, Volume and Issue: 8(25), P. 23148 - 23167

Published: June 12, 2023

Molecular generative artificial intelligence is drawing significant attention in the drug design community, with several experimentally validated proof of concepts already published. Nevertheless, models are known for sometimes generating unrealistic, unstable, unsynthesizable, or uninteresting structures. This calls methods to constrain those algorithms generate structures drug-like portions chemical space. While concept applicability domains predictive well studied, its counterpart not yet well-defined. In this work, we empirically examine various possibilities and propose suited models. Using both public internal data sets, use novel that predicted be actives by a corresponding quantitative structure-activity relationships model while constraining stay within given domain. Our work looks at domain definitions, combining criteria, such as structural similarity training set, physicochemical properties, unwanted substructures, estimate drug-likeness. We assess generated from qualitative points view find definitions have strong influence on drug-likeness molecules. An extensive analysis our results allows us identify best molecules anticipate will help foster adoption an industrial context.

Language: Английский

Citations

18

Identifying Substructures That Facilitate Compounds to Penetrate the Blood–Brain Barrier via Passive Transport Using Machine Learning Explainer Models DOI Creative Commons

Lucca Caiaffa Santos Rosa,

Caio Oliveira Argolo,

Cayque Monteiro Castro Nascimento

et al.

ACS Chemical Neuroscience, Journal Year: 2024, Volume and Issue: 15(11), P. 2144 - 2159

Published: May 9, 2024

The local interpretable model-agnostic explanation (LIME) method was used to interpret two machine learning models of compounds penetrating the blood–brain barrier. classification models, Random Forest, ExtraTrees, and Deep Residual Network, were trained validated using barrier penetration dataset, which shows penetrability in LIME able create explanations for such penetrability, highlighting most important substructures molecules that affect drug simple intuitive outputs prove applicability this explainable model interpreting permeability across terms molecular features. filtered with a weight equal or greater than 0.1 obtain only relevant explanations. results showed several structures are penetration. In general, it found some nitrogenous more likely permeate application these structural may help pharmaceutical industry potential synthesis research groups synthesize active rationally.

Language: Английский

Citations

8